China NMPA Product Recall - subcutaneous electrodes

On August 24, 2015, Medtronic (Shanghai) Management Co., Ltd., operating as the responsible unit in China for manufacturer Medtronic Xomed, Inc., announced a voluntary Class III recall concerning subcutaneous electrodes. This regulatory action, overseen by the National Medical Products Administration (NMPA), stemmed from an identified mislabeling issue. The affected medical devices were erroneously marked with an "8-year validity period," conflicting with the "4-year validity period" legally mandated under Chinese registration requirements. The recall involved 438 units of subcutaneous electrodes, product models 8227411, 8227412, 8227465, and 8227103, which are designed for subcutaneous placement and use with neuromonitoring systems to record electrical signals. Medtronic’s internal assessment determined that, despite the labeling error, the misstatement did not pose a health hazard, as scientific evidence supported the product's packaging and sterility maintaining an 8-year shelf life. Therefore, no adverse health consequences were anticipated from continued use. However, to address the regulatory non-compliance, Medtronic outlined specific corrective actions. These included issuing notification letters to all affected customers and facilitating the replacement of the mislabeled products. Furthermore, the company was mandated to retrieve and subsequently destroy all recalled units to align with the NMPA's stringent medical device standards. This comprehensive approach aimed to rectify the labeling discrepancy and uphold product integrity within the Chinese market.